• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Rendever Awarded $2M NIH Grant to Research Impact of Virtual Reality on Aging Population

by Jasmine Pennic 08/18/2021 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print
Rendever Awarded $2M NIH Grant to Research Impact of Virtual Reality on Aging Population

What You Should Know:

– Rendever, a Boston-based virtual reality (VR) platform built to help seniors overcome social isolation through shared experiences, announces that it has been awarded a $2M Phase II Grant from the National Institute on Aging (NIA), a division of the National Institutes of Health (NIH).

– This grant will fund a registered multi-site clinical trial, in conjunction with the University of California Santa Barbara, to further Rendever’s continued research on the effects of VR on seniors. The focus of the research is to evaluate the impact of VR-based virtual family engagement for seniors and the differences in effect across various levels of cognitive impairment (MCI, mild to moderate AD/ADRD).


How VR Reduces Harmful Effects of Social Isolation in Seniors

The Phase II Grant builds on Rendever’s previously awarded Small Business Technology Transfer (STTR) Phase I Grant to measure the impact of Rendever’s engagement platform. The initial pilot data confirmed the positive impact that virtual family engagement has on both residents and their family members living at a distance. Residents experienced decreased negative emotions and feelings of isolation, increased positive emotions and engagement with their family members, and overall improved quality of life. Family members reported similar mental health benefits along with significant decreases in caregiver guilt after using Rendever’s VR platform with their loved ones.

The data collection is expected to be conducted through the end of 2022 and the study will include approximately 400 participants in 12 senior living communities in the greater Boston area and central California. With uncertainty around the COVID-19 pandemic, the team is also prepared for remote collaboration for safety purposes as needed.

“We see the first-hand effects of our virtual reality platform every day through our community partners. We’re trailblazing toward a future in which communities thrive beyond the four walls of the physical building. This clinical trial is truly the first of its kind, and will help us continue to push the boundaries of what we think is possible through VR,” said Kyle Rand, Cofounder and CEO of Rendever. “The future of the industry will be enabled through technology that not only builds thriving communities, but also maintains the important social connections that exist before a resident moves in. We are incredibly grateful for the hard work and enthusiasm that is going into this study, and are eager to officially launch Phase II.”

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Aging Care, NIH, Senior Care, Therapeutic Virtual Reality, Virtual Reality

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |